Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD

摘要

ObjectiveThe effect of antacid therapy for patients with COPD and gastroesophageal reflux disease (GERD) remains unclear.